MLYS logo

Mineralys Therapeutics, Inc. (MLYS) Cash From Investing

Annual CFI:

$114.96M+$275.43M(+171.64%)
December 31, 2024

Summary

  • As of today, MLYS annual cash from investing is $114.96 million, with the most recent change of +$275.43 million (+171.64%) on December 31, 2024.
  • During the last 3 years, MLYS annual cash from investing has risen by +$114.96 million (+100.00%).
  • MLYS annual cash from investing is now at all-time high.

Performance

MLYS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYScash flow metrics

Quarterly CFI:

-$150.51M-$107.63M(-250.99%)
September 30, 2025

Summary

  • As of today, MLYS quarterly cash from investing is -$150.51 million, with the most recent change of -$107.63 million (-250.99%) on September 30, 2025.
  • Over the past year, MLYS quarterly cash from investing has dropped by -$230.11 million (-289.07%).
  • MLYS quarterly cash from investing is now -280.10% below its all-time high of $83.57 million, reached on December 31, 2024.

Performance

MLYS Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYScash flow metrics

TTM CFI:

-$202.69M-$230.11M(-839.27%)
September 30, 2025

Summary

  • As of today, MLYS TTM cash from investing is -$202.69 million, with the most recent change of -$230.11 million (-839.27%) on September 30, 2025.
  • Over the past year, MLYS TTM cash from investing has dropped by -$225.99 million (-969.93%).
  • MLYS TTM cash from investing is now -276.32% below its all-time high of $114.96 million, reached on December 31, 2024.

Performance

MLYS TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYScash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MLYS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+171.6%-289.1%-969.9%
3Y3 Years+100.0%-109.7%-182.5%
5Y5 Years+100.0%--

MLYS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+171.6%-280.1%at low-276.3%at low
5Y5-Yearat high+171.6%-280.1%at low-276.3%at low
All-TimeAll-Timeat high+171.6%-280.1%at low-276.3%at low

MLYS Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$150.51M(-251.0%)
-$202.69M(-839.3%)
Jun 2025
-
-$42.88M(+53.8%)
$27.42M(-64.9%)
Mar 2025
-
-$92.88M(-211.1%)
$78.03M(-32.1%)
Dec 2024
$114.96M(+171.6%)
$83.57M(+5.0%)
$114.96M(+393.4%)
Sep 2024
-
$79.61M(+929.0%)
$23.30M(+144.6%)
Jun 2024
-
$7.74M(+113.8%)
-$52.30M(+31.3%)
Mar 2024
-
-$55.95M(-591.7%)
-$76.17M(+52.5%)
Dec 2023
-$160.47M
-$8.09M(-301.9%)
-$160.47M(-56.7%)
DateAnnualQuarterlyTTM
Sep 2023
-
$4.01M(+124.8%)
-$102.38M(+42.5%)
Jun 2023
-
-$16.14M(+88.5%)
-$178.15M(-10.0%)
Mar 2023
-
-$140.25M(-380.5%)
-$162.01M(-644.6%)
Dec 2022
-$21.76M(>-9900.0%)
$50.00M(+169.7%)
-$21.76M(+69.7%)
Sep 2022
-
-$71.76M(>-9900.0%)
-$71.76M(>-9900.0%)
Jun 2022
-
$0.00
$0.00
Dec 2021
$0.00(0.0%)
-
-
Dec 2020
$0.00
-
-

FAQ

  • What is Mineralys Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Mineralys Therapeutics, Inc.?
  • What is Mineralys Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Mineralys Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Mineralys Therapeutics, Inc.?
  • What is Mineralys Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Mineralys Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Mineralys Therapeutics, Inc.?
  • What is Mineralys Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Mineralys Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of MLYS is $114.96M

What is the all-time high annual cash from investing for Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. all-time high annual cash from investing is $114.96M

What is Mineralys Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, MLYS annual cash from investing has changed by +$275.43M (+171.64%)

What is Mineralys Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of MLYS is -$150.51M

What is the all-time high quarterly cash from investing for Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. all-time high quarterly cash from investing is $83.57M

What is Mineralys Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, MLYS quarterly cash from investing has changed by -$230.11M (-289.07%)

What is Mineralys Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of MLYS is -$202.69M

What is the all-time high TTM cash from investing for Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. all-time high TTM cash from investing is $114.96M

What is Mineralys Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, MLYS TTM cash from investing has changed by -$225.99M (-969.93%)
On this page